Genomic Applications Using Oligonucleotide-based DNA Microarrays

05/20/2008 - 12:00pm
05/20/2008 - 2:30pm
Location: 
114/116/118 AAB (Academic and Administration Building)

Speaker: Scott J. Vacha, Ph.D. (Agilent Technologies)

Sponsor: Ryan S. Robetorye, M.D., Ph.D.
Director, Agilent Technologies Core Laboratory, UTHSCSA/CTRC Cancer Center

This technical presentation will highlight new
applications with Agilent DNA microarrays including:
oligo library synthesis, copy number/CNV detection,
FFPE labeling, miRNA analysis, genome-wide
methylation, and eArray tools for free high-density
custom microarray design.
Why outsource or duplicate efforts? Come learn what
genomics capabilities are already available to you at
UTHSCSA using existing Agilent equipment.
PIZZA WILL BE SERVED


Cancer Development and Progression Program Retreat

05/09/2008 - 9:30am
05/09/2008 - 4:30pm
Location: 
Where: SBC Teleconference Center, Texas Research Park

Topic: Cancer and Stem Cells
This all-day symposium will feature outstanding speakers who will address the topic of the interaction of stem cell biology and cancer.
Organizers: Peter Hornsby; Z. Dave Sharp; Rong Li; Vivienne Rebel; Jaclyn Hung; John McCarrey
For more information please contact Ms. Diana Hottle (hottle@uthscsa.edu )


Spring 2008 Molecular Medicine Series: “BRCA1 and its downstream genes in genome integrity, cancer and aging.”

03/25/2008 - 3:30pm
03/25/2008 - 4:30pm
Location: 
Texas Research Park Campus, IBT Conference Room 3.002

Chuxia Deng, Ph.D., Chief, Mammalian Genetics Section, National Institutes of Health, NIDDK.
“BRCA1 and its downstream genes in genome integrity, cancer and aging.”
Tuesday, March 25, 2008, 3:30 – 4:30 p.m., IBT Conference Room 3.002, Texas Research Park Campus.


Drug Development Lecture

03/12/2008 - 4:00pm
03/12/2008 - 5:00pm

There will be a Drug Development Lecture on Wednesday, March 12th, 2008 from 4:00-5:00pm in the Large Conference Room (Z401) Zeller Bldg
Guest Speaker- Dr. John E. Pippen Breast cancer specialist with the Baylor Sammons Cancer Center in Dallas
Topic of Discussion- “An Update in the Treatment of HER2+ Advanced or Metastatic Breast Cancer”


About CTRC @ UTHSCSA

The Cancer Therapy & Research Center (CTRC), located in San Antonio, Texas, became a center of The University of Texas Health Science Center at San Antonio in December 2007. The University of Texas System Board of Regents, meeting Dec. 6 in Austin, authorized the acquisition of the CTRC by the Health Science Center. The merger took effect Dec. 17.

The cancer center is now named the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center at San Antonio. The CTRC at the UT Health Science Center is a patient care, research and educational center of the Health Science Center School of Medicine.

Before the merger, the two institutions were partners in the San Antonio Cancer Institute, one of the three National Cancer Institute (NCI)-designated Cancer Centers in Texas. The San Antonio Cancer Institute name has been discontinued. The CTRC at the UT Health Science Center is now the NCI-designated Cancer Center.

Tyler J. Curiel, M.D., M.P.H., an internationally known medical oncologist and cancer researcher, has been named director of the cancer center. Frank Giles, M.D., M.B., FRCPI, FRCPath, has been promoted to deputy director of the cancer center and continues as director of the CTRC Institute for Drug Development and experimental therapeutics program.

“As historically strong partners, the Health Science Center and CTRC provided quality patient care, research and prevention, and other educational efforts to South Texas and the state,” said Francisco G. Cigarroa, M.D., president of the UT Health Science Center. “Now as we welcome the CTRC into our Health Science Center family, we possess a bold, singular vision for the future — development of an even greater world-premier cancer center that, backed by the power of academic research discovery, provides better lives to cancer patients and their families.”